NEW YORK (GenomeWeb) – Transgenomic today announced that it has amended its license agreement with Exiqon to include the rights to Exiqon's locked nucleic acid (LNA) oligonucleotides.

The new agreement provides Transgenomic with access to LNA oligos for use with all of its mutation enrichment technologies, including multiplexed ICE COLD-PCR. It also covers worldwide commercial use of LNA oligos for analysis of all cancer genes on all platforms, including next-generation sequencing.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.